The rectal cancer survival rate is a statistic that is commonly used by medical professionals as a general guideline when discussing patient outcomes.
The rectal cancer survival rate is trending upward, and Moffitt Cancer Center is committed to continuing this progress until a cure is available for all patients. That’s why our team of researchers and oncologists:
- Designs an individualized treatment plan for each patient, taking the time to account for the unique factors that can influence the patient’s outcome.
- Provides patients with opportunities to enroll in clinical trials, if so desired, so that they can be among the first to benefit from promising new rectal cancer treatment options.
- Actively develops better early detection tools, increasing the number of patients who are diagnosed in early stages and have correspondingly better prognoses.
Individuals who would like to learn more about the rectal cancer survival rate or the specific factors that could impact their own outcomes can come to Moffitt Cancer Center. Referrals are not required to make an appointment. To plan your visit, call 1-888-663-3488 or submit a new patient registration form online.